TR-1: NOTIFICATION OF MAJOR INTEREST IN
SHARESi | |||||
1. Identity of the issuer or the underlying
issuer of existing shares to which voting rights are attached:ii |
Tissue Regenix Group plc | ||||
2 Reason for the notification(please tick the
appropriate box or boxes): | |||||
An acquisition or disposal of voting
rights |
X | ||||
An acquisition or disposal of qualifying
financial instruments which may result in the
acquisition of shares already issued to which voting
rights are attached | |||||
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments | |||||
An event changing the breakdown of voting
rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to the notification obligation:iii |
Invesco Limited | ||||
4. Full name of shareholder(s) (if different from 3.):iv | |||||
5. Date of the transaction and date on which the threshold is crossed or reached:v |
10 January 2012 | ||||
6. Date on which issuer notified: |
11 January 2012 | ||||
7. Threshold(s) that is/are crossed or reached:vi, vii |
27%, 28% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to sharesviii,
ix | ||||||||||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction |
Resulting situation after the triggering
transaction | ||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
Direct |
Directxi |
Indirectxii |
Direct |
Indirect | ||||||||||||
Ordinary GBP0.005 Shares |
176,457,019 |
176,457,019 |
186,457,019 |
28.58% | ||||||||||||
GB00B5SGVL29 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering
transaction | ||||||||||||||||
Type of financial instrument |
Expiration datexiii |
Exercise/ Conversion Periodxiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights | ||||||||||||
C: Financial Instruments with similar economic
effect to Qualifying Financial Instrumentsxv,
xvi | ||||||||||||||||
Resulting situation after the triggering
transaction | ||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration datexvii |
Exercise/ Conversion periodxviii |
Number of voting rights instrument refers
to |
% of voting rightsxix, xx | |||||||||||
Nominal |
Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights |
Percentage of voting rights | |||||||||||||||
186,457,019 |
28.58% | |||||||||||||||
9. Chain of controlled undertakings through which
the voting rights and/or the financial instruments are effectively held, if applicable:xxi | ||
Bank of New York - 177580,983 State Street Trust & Banking Co (London) -
8,876,036 | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will
cease to hold: | ||
12. Date on which proxy holder will cease to hold
voting rights: | ||
13. Additional information: | ||
14. Contact name: |
Samantha Edwards | |
15. Contact telephone number: |
01491 416381 | |
This information is provided by RNS
distribué par | Ce noodl a été diffusé par Tissue Regenix Group plc et initialement mise en ligne sur le site http://www.tissueregenix.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-11 12:50:02 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |